Literature DB >> 21082387

Blood-brain barrier disruption in the treatment of brain tumors.

Marie Blanchette1, David Fortin.   

Abstract

Standard chemotherapy administered systemically has a limited efficacy in the treatment of brain tumors. One of the major obstacles in the treatment of brain neoplasias is the impediment to delivery across the intact blood-brain barrier (BBB). Many innovative approaches have been developed to circumvent this obstacle. One such strategy is BBB disruption (BBBD), which successfully increases the delivery of antineoplastic agents to the central nervous system (CNS). This chapter describes the application of the BBBD technique in rats. Different methods to evaluate and measure BBB permeability following hyperosmolar mannitol infusion including Evans blue staining, albumin immunohistochemistry, and dynamic magnetic resonance imaging are also described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21082387     DOI: 10.1007/978-1-60761-938-3_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

1.  Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  J Neurooncol       Date:  2013-09-13       Impact factor: 4.130

Review 2.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

3.  Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

Authors:  Antonella Mangraviti; Stephany Y Tzeng; David Gullotti; Kristen L Kozielski; Jennifer E Kim; Michael Seng; Sara Abbadi; Paula Schiapparelli; Rachel Sarabia-Estrada; Angelo Vescovi; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green; Alfredo Quinones-Hinojosa
Journal:  Biomaterials       Date:  2016-05-21       Impact factor: 12.479

4.  Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice.

Authors:  Jacqueline J Glascock; Erkan Y Osman; Tristan H Coady; Ferrill F Rose; Monir Shababi; Christian L Lorson
Journal:  J Vis Exp       Date:  2011-10-03       Impact factor: 1.355

5.  Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.

Authors:  Marie Blanchette; Luc Tremblay; Martin Lepage; David Fortin
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

6.  Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats.

Authors:  Xuhui Bao; Vidyalakshmi Chandramohan; Randall P Reynolds; John N Norton; William C Wetsel; Ramona M Rodriguiz; Dipendra K Aryal; Roger E McLendon; Edward D Levin; Neil A Petry; Michael R Zalutsky; Bruce K Burnett; Chien-Tsun Kuan; Ira H Pastan; Darell D Bigner
Journal:  Invest New Drugs       Date:  2016-01-04       Impact factor: 3.850

Review 7.  Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier.

Authors:  Gabriel S Gonzales-Portillo; Paul R Sanberg; Max Franzblau; Chiara Gonzales-Portillo; Theo Diamandis; Meaghan Staples; Cyndy D Sanberg; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2014-01-29       Impact factor: 4.064

8.  Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid.

Authors:  Yu Zhang; Jason S Buhrman; Yang Liu; Jamie E Rayahin; Richard A Gemeinhart
Journal:  Mol Pharm       Date:  2016-05-23       Impact factor: 4.939

Review 9.  Crossing the barrier: treatment of brain tumors using nanochain particles.

Authors:  Efstathios Karathanasis; Ketan B Ghaghada
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-09

Review 10.  Therapeutic nanomedicine for brain cancer.

Authors:  Stephany Y Tzeng; Jordan J Green
Journal:  Ther Deliv       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.